Can I read When Cardiovascular Medicines Should Be Discontinued on EtoBox?

When Cardiovascular Medicines Should Be Discontinued by Konstantin A. Krychtiuk & Bernard J. Gersh & Jeffrey B. Washam & Christopher B. Granger is a book available to read on EtoBox.

What is When Cardiovascular Medicines Should Be Discontinued about?

DOI: 10.1093/eurheartj/ehae302; European Heart Journal, 00, 0, 2024-06-05.; Abstract: Graphical Abstract: Graphical Abstract Cardiovascular medicines that should either be deprescribed to prevent harm or for a lack of benefit or be switched to better alternatives. OAC, oral anticoagulation; AFIB, atrial fibrillation; ASCVD, atherosclerotic cardiovascular disease; HFrEF, heart failure with reduced ejection fraction; DPP-4, dipeptidyl peptidase-4; CVD, cardiovascular disease; DAPT, dual antiplatelet therapy; NSAID, non-steroidal anti-inflammatory drug; RAAS, renin–angiotensin–aldosterone system; AMI, acute myocardial infarction; SAMS, statin-associated muscle symptoms; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ACS, acute coronary syndrome.

Author

Konstantin A. Krychtiuk & Bernard J. Gersh & Jeffrey B. Washam & Christopher B. Granger

Publisher

Oxford University Press

Published

2024

Language

EN